| Literature DB >> 34089935 |
Bai Wei1, Ke Shang1, Se-Yeoun Cha1, Jun-Feng Zhang1, Hyung-Kwan Jang2, Min Kang3.
Abstract
The aim of this study was to determine the prevalence, serovar distribution, antimicrobial resistance, and genotypic analyses of the dominating serovars of Salmonella in chickens from a national study in Korea. Between 2017 and 2018, a total of 550 chicken samples were collected from the top 12 integrated broiler chicken operations in Korea. Salmonella was isolated from 117 (32.5%) chicken feces and 19 (10.0%) retail chicken meat sources. Ten serovars were identified, and the most common Salmonella serovar was Salmonella ser. Albany (50 isolates, 36.8%), followed by S. Enteritidis (38 isolates, 27.9%), and S. Montevideo (23 isolates, 16.9%) isolated from 6, 10, and 6 operations, respectively. A total of 35 (25.7%) isolates were with the ACSSuTN (ampicillin, chloramphenicol, streptomycin, sulfisoxazole, tetracycline, and nalidixic acid) resistance pattern, with high prevalence of this resistance pattern in S. Albany (29 isolates, 58.0%). A total of 35 PFGE types were identified among Salmonella isolates of the serovars Albany, Enteritidis, Virchow, Montevideo, and Senftenberg, while 11 distinct types of PFGE patterns were found among S. Albany isolates, which showed an overall homology similarity of higher than 85%. Among these 35 PFGE types, 22 PFGE types corresponded to 32 isolates from samples limited to one operation, and the other 13 PFGE types corresponded to 72 isolates from samples widely distributed among different operations. These results highlighted rapid colony dissemination of multidrug-resistant S. Albany in chicken all over Korea after it first appeared in 2016; furthermore, the spread of Salmonella colonies between various integrated operations was common, and several operations played an important role in Salmonella carriage and transmission in Korea.Entities:
Keywords: Integrated chicken operations; S. Albany; antimicrobial resistance; colony dissemination; salmonella
Mesh:
Substances:
Year: 2021 PMID: 34089935 PMCID: PMC8182268 DOI: 10.1016/j.psj.2021.101141
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Prevalence of Salmonella isolates in broiler chicken feces and retail meat from 12 operations in South Korea.
| Operation | Total | Feces | Retail meat | |||
|---|---|---|---|---|---|---|
| No. of samples/farms | Positive No. (%) of samples/farms | No. of samples/farms | Positive No. (%) of samples/farms | No. of samples/farms | Positive No. (%) of samples/farms | |
| C1 | 60/12 | 15 (25.0)/7 (58.3) | 40/8 | 8 (20.0)/4 (50.0) | 20/4 | 7 (35.0)/3 (75.0) |
| C2 | 60/12 | 11 (18.3)/6 (50.0) | 40/8 | 9 (22.5)/5 (62.5) | 20/4 | 2 (10.0)/1 (25.0) |
| C3 | 30/6 | 2 (6.7)/2 (33.3) | 20/4 | 2 (10.0)/2 (50.0) | 10/2 | 0 (0.0)/0 (0.0) |
| C4 | 30/6 | 14 (46.7)/6 (100.0) | 20/4 | 8 (40.0)/4 (100.0) | 10/2 | 6 (60.0)/2 (100.0) |
| C5 | 60/12 | 15 (25.0)/5 (41.7) | 40/8 | 15 (37.5)/5 (62.5) | 20/4 | 0 (0.0)/0 (0.0) |
| C6 | 60/12 | 29 (48.3)/8 (66.7) | 40/8 | 27 (67.5)/7 (87.5) | 20/4 | 2 (10.0)/1 (25.0) |
| C7 | 30/6 | 10 (33.3)/3 (50.0) | 20/4 | 10 (50.0)/3 (75.0) | 10/2 | 0 (0.0)/0 (0.0) |
| C8 | 40/8 | 8 (20.0)/3 (37.5) | 20/4 | 8 (40.0)/3 (75.0) | 20/4 | 0 (0.0)/0 (0.0) |
| C9 | 60/12 | 15 (25.0)/7 (58.3) | 40/8 | 13 (32.5)/5 (62.5) | 20/4 | 2 (10.0)/2 (50.0) |
| C10 | 30/6 | 6 (20.0)/3 (50.0) | 20/4 | 6 (30.0)/3 (75.0) | 10/2 | 0 (0.0)/0 (0.0) |
| C11 | 45/9 | 10 (22.2)/3 (33.3) | 30/6 | 10 (33.3)/3 (50.0) | 15/3 | 0 (0.0)/0 (0.0) |
| C12 | 45/9 | 1 (2.2)/1 (11.1) | 30/6 | 1 (3.3)/1 (16.7) | 15/3 | 0 (0.0)/0 (0.0) |
| Total | 550/110 | 136 (24.7)/54 (49.1) | 360/72 | 117 (32.5)/45 (62.5) | 190/38 | 19 (10.0)/9 (23.7) |
Distribution of Salmonella serovars among 12 operations.
| Operation | Serovar (No.) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Albany | Enteritidis | Montevideo | Virchow | Senftenberg | Rissen | Mbandaka | Alminko | Typhimurium | Moscow | ||
| C1 (n = 15) | 7 | 4 | 1 | 3 | |||||||
| C2 (n = 11) | 6 | 1 | 4 | ||||||||
| C3 (n = 2) | 1 | 1 | |||||||||
| C4 (n = 14) | 6 | 2 | 6 | ||||||||
| C5 (n = 15) | 9 | 5 | 1 | ||||||||
| C6 (n = 29) | 22 | 1 | 3 | 1 | 2 | ||||||
| C7 (n = 10) | 2 | 7 | 1 | ||||||||
| C8 (n = 8) | 8 | ||||||||||
| C9 (n = 15) | 4 | 8 | 2 | 1 | |||||||
| C10 (n = 6) | 3 | 1 | 1 | 1 | |||||||
| C11 (n = 10) | 5 | 4 | 1 | ||||||||
| C12 (n = 1) | 1 | ||||||||||
| Total (n = 136) | 50 | 38 | 23 | 6 | 5 | 3 | 3 | 1 | 1 | 1 | 5 |
Antimicrobial resistance of Salmonella isolates among 12 operations (resistance No./%).
| Antimicrobial agent | Operation | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C1 (n = 15) | C2(n = 11) | C3(n = 2) | C4(n = 14) | C5(n = 15) | C6(n = 29) | C7(n = 10) | C8(n = 8) | C9(n = 15) | C10(n = 6) | C11(n = 10) | C12(n = 1) | Total (n = 136) | |
| Amoxicillin/ clavulanic acid | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Ampicillin | 8 | 10 | 1 | 12 | 14 | 21 | 8 | 8 | 3 | 4 | 5 | 1 | 95 |
| Cefoxitin | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Ceftazidime | 0 | 1 | 0 | 11 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 16 |
| Ceftiofur | 0 | 1 | 0 | 12 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 17 |
| Cefepime | 0 | 0 | 0 | 11 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 15 |
| Meropenem | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trimethoprim/ sulfamethoxazole | 0 | 6 | 0 | 4 | 9 | 26 | 2 | 8 | 0 | 4 | 0 | 0 | 59 |
| Sulfisoxazole | 8 | 9 | 1 | 7 | 14 | 26 | 8 | 8 | 1 | 4 | 5 | 1 | 92 |
| Chloramphenicol | 0 | 5 | 0 | 4 | 9 | 20 | 2 | 8 | 1 | 5 | 0 | 0 | 54 |
| Ciprofloxacin | 0 | 1 | 0 | 1 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Nalicixic acid | 12 | 11 | 1 | 14 (100.0) | 15 | 29 | 8 | 8 | 15 | 4 | 10 | 1 | 128 |
| Streptomycin | 9 | 7 | 2 | 7 | 10 | 19 | 7 | 5 | 1 | 2 | 6 | 1 | 76 |
| Gentamicin | 0 | 0 | 0 | 6 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Tetracycline | 0 | 6 | 1 | 12 | 13 | 22 | 8 | 8 | 3 | 3 | 5 | 1 | 82 |
| Colistin | 2 | 0 | 0 | 1 | 5 | 1 | 4 | 0 | 1 | 0 | 2 | 0 | 16 |
Antimicrobial resistance among different Salmonella serovar.
| Antimicrobial agent | Serovar (No./%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Albany (n = 50) | Enteritidis (n = 38) | Montevideo (n = 23) | Virchow (n = 6) | Senftenberg (n = 5) | Rissen (n = 3) | Mbandaka (n = 3) | Alminko (n = 1) | Typhimurium (n = 1) | Moscow (n = 1) | ||
| Amoxicillin/ clavulanic acid | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ampicillin | 44 | 34 | 3 | 6 | 1 | 2 | 0 | 1 | 1 | 1 | 2 |
| Cefoxitin | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ceftazidime | 1 | 8 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Ceftiofur | 1 | 9 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Cefepime | 0 | 8 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Meropenem | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trimethoprim/ sulfamethoxazole | 50 | 1 | 0 | 3 | 0 | 2 | 0 | 1 | 1 | 0 | 1 |
| Sulfisoxazole | 50 | 27 | 2 | 6 | 1 | 1 | 0 | 1 | 1 | 1 | 2 |
| Chloramphenicol | 43 | 2 | 0 | 3 | 0 | 2 | 0 | 1 | 1 | 0 | 2 |
| Ciprofloxacin | 3 | 1 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
| Nalicixic acid | 50 | 36 | 23 | 6 | 5 | 3 | 0 | 1 | 0 | 1 | 3 |
| Streptomycin | 32 | 27 | 3 | 6 | 1 | 2 | 1 | 0 | 0 | 1 | 3 |
| Gentamicin | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tetracycline | 44 | 25 | 0 | 6 | 0 | 3 | 0 | 1 | 0 | 1 | 2 |
| Colistin | 2 | 11 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Resistance pattern of Salmonella isolates from chicken.
| No. | Antimicrobial resistance pattern | No. of isolates | ||||||
|---|---|---|---|---|---|---|---|---|
| Albany (n = 50) | Enteritidis (n = 38) | Montevideo (n = 23) | Virchow (n = 6) | Senftenberg (n = 5) | Others (n = 14) | Total (n = 136) | ||
| 0 | - | 2 | 2 | 4 | ||||
| 1 | AMP | 1 | 1 | |||||
| 2 | CHL | 1 | 1 | |||||
| 3 | NAL | 1 | 18 | 4 | 1 | 24 | ||
| 4 | STR | 2 | 2 | |||||
| 5 | NAL/COL | 1 | 1 | |||||
| 6 | NAL/TET | 1 | 1 | |||||
| 7 | CHL/NAL/COL | 1 | 1 | |||||
| 8 | NAL/STR/COL | 1 | 1 | |||||
| 9 | SXT/FIS/NAL | 4 | 4 | |||||
| 10 | AMP/FIS/NAL/STR | 7 | 2 | 1 | 10 | |||
| 11 | AMP/SXT/FIS/CHL | 1 | 1 | |||||
| 12 | SXT/FIS/NAL/STR | 2 | 2 | |||||
| 13 | AMP/FIS/NAL/STR/COL | 2 | 2 | |||||
| 14 | AMP/FIS/NAL/STR/TET | 9 | 9 | |||||
| 15 | AMP/FIS/NAL/STR/TET/COL | 7 | 1 | 8 | ||||
| 16 | AMP/SXT/FIS/CHL/NAL/TET | 11 | 1 | 12 | ||||
| 17 | AMP/SXT/FIS/NAL/STR/TET | 1 | 1 | |||||
| 18 | AMP/TAZ/XNL/FEP/NAL/TET | 2 | 2 | |||||
| 19 | AMP/SXT/CHL/CIP/NAL/STR/TET | 1 | 1 | |||||
| 20 | AMP/SXT/FIS/CHL/NAL/STR/TET | 25 | 1 | 26 | ||||
| 21 | AMP/SXT/FIS/CHL/NAL/TET/COL | 1 | 1 | |||||
| 22 | AMP/TAZ/XNL/FEP/NAL/GEN/TET | 5 | 5 | |||||
| 23 | AUG2/AMP/SXT/FIS/CHL/NAL/TET | 1 | 1 | |||||
| 24 | AMP/SXT/FIS/CHL/CIP/NAL/STR/TET | 3 | 1 | 4 | ||||
| 25 | AMP/SXT/FIS/CHL/NAL/STR/TET/COL | 1 | 1 | |||||
| 26 | AMP/TAZ/XNL/FEP/FIS/NAL/STR/TET | 3 | 1 | 4 | ||||
| 27 | AMP/TAZ/XNL/FEP/FIS/NAL/STR/GEN/TET | 1 | 1 | |||||
| 28 | AMP/TAZ/XNL/FEP/SXT/FIS/CHL/NAL/STR/TET | 3 | 3 | |||||
| 29 | AUG2/AMP/FOX/TAZ/XNL/SXT/FIS/CHL/NAL/TET | 1 | 1 | |||||
| 30 | AMP/XNL/SXT/FIS/CHL/CIP/NAL/STR/GEN/TET/COL | 1 | 1 | |||||
Figure 1Dendrograms based on Xba I-pulsed field gel electrophoresis (PFGE) profiles of Salmonella ser. Albany isolates from chicken and the corresponding antimicrobial susceptibility patterns to the 16 indicated antimicrobials. The Dice coefficient was used to perform similarity analysis. The antimicrobials shown in the sequence are amoxicillin/clavulanic acid (AUG2), ampicillin (AMP), cefoxitin (FOX), ceftazidime (TAZ), ceftiofur (XNL), cefepime (FEP), meropenem (MERO), trimethoprim/sulfamethoxazole (SXT), sulfisoxazole (FIS), chloramphenicol (CHL), ciprofloxacin (CIP), nalicixic acid (NAL), streptomycin (STR), gentamicin (GEN), tetracycline (TET), and colistin (COL).
Figure 2Dendrograms based on Xba I-pulsed field gel electrophoresis (PFGE) profiles of Salmonella ser. Enteritidis isolates from chicken and the corresponding antimicrobial susceptibility patterns to the 16 indicated antimicrobials.
Figure 3Dendrograms based on Xba I-pulsed field gel electrophoresis (PFGE) profiles of Salmonella ser. Montevideo (A), S. Virchow (B), and S. Senftenberg (C) isolates from chicken and the corresponding antimicrobial susceptibility patterns to the 16 indicated antimicrobials.
Figure 4Overlap each of the PFGE types of Salmonella ser. Albany, S. Enteritidis, S. Montevideo, S. Virchow, and S. Senftenberg from one operation to other operations.